Jonathan Anderman, General Counsel and Corporate Secretary of Compass Therapeutics, Inc. ($CMPX), made one open market purchase of company shares worth $30,800 in the last 365 days, with the most recent on April 7, 2025. This ranks him 3,406th among 4,983 insiders in our database by purchase amount, below the average of $1.46 million across 3.29 transactions per insider. He reported no open market sales during this period.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan. 2, 2026 | Compass Therapeutics, Inc. | $CMPX | Anderman Jonathan | General Counsel | A | Common Stock | 150000 | $5.17 | 171,000.0000 | 177,862,102 | 714.29% | 0.08% |
| Jan. 2, 2026 | Compass Therapeutics, Inc. | $CMPX | Anderman Jonathan | General Counsel | A | Stock Option (Right to Buy) | 720000 | $0.00 | 720,000.0000 | 177,862,102 | 9999.99% | 0.40% |
| April 7, 2025 | Compass Therapeutics, Inc. | $CMPX | Anderman Jonathan | Gen Counsel & Corporate Sec | P | Common Stock | 20000 | $1.54 | 21,000.0000 | 138,282,498 | 2000.00% | 0.01% |
| Feb. 11, 2025 | Compass Therapeutics, Inc. | $CMPX | Anderman Jonathan | Sr VP, Gen Counsel & Corp Sec | A | Stock Option (Right to Buy) | 280000 | $0.00 | 280,000.0000 | 0 | 9999.99% | 0.00% |
| Aug. 13, 2024 | Compass Therapeutics, Inc. | $CMPX | Anderman Jonathan | Sr VP, Gen Counsel & Corp Sec | A | Stock Option (Right to Buy) | 300000 | $0.00 | 300,000.0000 | 0 | 9999.99% | 0.00% |